This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Andrey S Selyunin
Introduction
Andrey S Selyunin is an accomplished inventor based in Kyle, TX (US). He has made significant contributions to the field of medical treatments, particularly in addressing Shiga toxicosis. His innovative approaches have the potential to improve patient outcomes and advance therapeutic options.
Latest Patents
One of his notable patents is titled "Methods and compositions for the treatment of Shiga Toxicosis." This patent outlines methods for treating Shiga toxicosis, which is caused by infection with Shiga toxin bacteria. The methods include administering an effective amount of one or more active agents, such as tamoxifen, 4-hydroxytamoxifen, endoxifen, toremifene, raloxifene, bazedoxifene, and their pharmaceutically acceptable salts. Additionally, the methods may involve the administration of an antibiotic or a manganese compound to the subject. Pharmaceutical compositions for the treatment of Shiga toxicosis are also described in this patent. Andrey holds 1 patent in total.
Career Highlights
Andrey S Selyunin is affiliated with the University of Texas System, where he continues to engage in research and development. His work focuses on innovative solutions to complex medical challenges, particularly in the realm of infectious diseases.
Collaborations
Andrey has collaborated with notable colleagues, including Somshuvra Mukhopadhyay and Stanton F McHardy. These collaborations have contributed to the advancement of research and the development of effective treatment methodologies.
Conclusion
Andrey S Selyunin's contributions to the field of medical innovation, particularly in the treatment of Shiga toxicosis, highlight his commitment to improving healthcare outcomes. His work exemplifies the impact of dedicated research and collaboration in the pursuit of medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
